Journal Article (Review Article)

DKFZ-2026-01868

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

Hartkopf, A. ; Albert, U.-S. ; Bartsch, R. ; Bauerfeind, I. ; Banys-Paluchowski, M. ; Bjelic-Radisic, V. ; Blohmer, J.-U. ; Dall, P. ; Fallenberg, E. M. ; Fasching, P. A. ; Friedrich, M. ; Gluz, O. ; Harbeck, N. ; Heil, J. ; Hörner-Rieber, J. ; Huober, J. ; Janni, W. ; Kreipe, H.-H. ; Krug, D. ; Kühn, T. ; Kümmel, S. ; Loibl, S. ; Lüftner, D. ; Lux, M. P. ; Maass, N. ; van Mackelenbergh, M. T. ; Mundhenke, C. ; Park-Simon, T.-W. ; Reinisch, M. ; Reimer, T. ; Rhiem, K. ; Rody, A. ; Schneeweiss, A.DKFZ* ; Schütz, F. ; Sinn, H.-P. ; Solbach, C. ; Solomayer, E.-F. ; Stickeler, E. ; Thill, M. ; Untch, M. ; Witzel, I. ; Wöckel, A. ; Wuerstlein, R. ; Ditsch, N. ; Fehm, T. ; Müller, V. ; Schmidt, M.

2026
Elsevier Amsterdam [u.a.]

Abstract: Biomarkers are integral to modern breast cancer management by providing essential information for prognosis and treatment selection. This review presents the 2026 update of the recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) on therapy-relevant prognostic and predictive biomarkers. The recommendations are based on a structured evaluation of the most recent and clinically relevant evidence using the AGO grading system to support decision-making in routine clinical practice.

Keyword(s): AGO recommendations ; Biomarker ; Breast cancer ; Systemic treatment ; Translational research

Note: #NCTZFB26#

---

Contributing Institute(s):

1. Koordinierungsstelle NCT Heidelberg (HD02)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026

---

Database coverage:
; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; Nationallizenz ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---